Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-14
1996-07-02
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4351723, 4352402, 4353201, 424 9321, 935 62, 935 57, 935 70, A61K 3170, A61K 4800, C12N 1500, C12N 500
Patent
active
055322204
ABSTRACT:
A method for utilizing p53 cDNA, and p53 gene products for the suppression of the neoplastic phenotype.
REFERENCES:
patent: 4497796 (1985-02-01), Salser et al.
Anderson, W. French, "Prospects for Human Gene Therapy." Science 246:401-409 (1984).
Angier, N., "Light Cast on a Darkling Gene." Discover Mar.:85-96 (1987).
Banks et al., "Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression." Eur. J. Biochem. 159:529-534 (1986).
Bookstein et al., "Human retinoblastoma susceptibility gene: Genomic organization and analysis of heterozygous intragenic deletion mutants." Proc. Natl. Acad. Sci. USA 85:2210-2214 (1988).
Bookstein et al., "Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene." Science 247:712-715 (1990).
Cattoretti et al., "Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas." Br. J. Cancer 57:353-357 (1988).
Cepko et al., "Construction and Applications of a Highly Transmissible Murine Retrovirus Shuttle Vector." Cell 37:1053-1062 (1984).
Chen et al., "Phosphorylation of the Retinoblastoma Gene Product Is Modulated during the Cell Cycle and Cellular Differentiation." Cell 58:1193-1198 (1989).
David et al., "Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus." Oncogene 3:179-185 (1988).
Dyson et al., "The Human Pailloma virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product." Science 243:934-937 (1989).
Eliyahu et al., "Wild-type p53 can inhibit oncogene-mediated focus formation." Proc. Natl. Acad. Sci USA 86:8763-8767 (1989).
Finlay et al., "The p53 Proto-Oncogene Can Act as a Suppressor of Transformation." Cell 57:1083-1093 (1989).
Friedmann, Theodore, "Gene Therapy of Cancer through Restoration of Tumor-Suppressor Functions?" Cancer 70:1810-1817 (1992).
Friend et al., "Deletions of a DNA sequence in retinoblastoma and mesenchymal tumors: Organization of the sequence and its encoded protein." Proc. Natl. Acad. Sci. USA 84:9059-9063 (1987).
Friend et al., "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma." Nature 323:643-646 (1986).
Fung et al., "Structural Evidence for the Authenticity of the Human Retinoblastoma Gene." Science 236:1657-1661 (1987).
Gossler et al., "Transgenesis by means of blastocyst-derived embryonic stem cell lines." Proc. Natl. Acad. Sci. USA 83:9065-9069 (1986).
Harlow et al., "Molecular Cloning and In Vitro Expression of a cDNA Clone for Human Cellular Tumor Antigen p53." Molecular and Cellular Biol. 5(7):1601-1610 (1985).
Harris, Henry, "Malignant tumours generated by recessive mutations." Nature 323:582-583 (1986).
Harris et al., "Molecular Basis for Heterogeneity of the Human p53 Protein." Molecular and Cellular Biol. 6(12) 4650-4656 (1986).
Hong et al., "Structure of the human retinoblastoma gene." Proc. Natl. Acad. Sci. USA 86:5502-5506 (1989).
Hooper et al., "HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells." Nature 326:292-295 (1987).
Hu et al., "The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations." The EMBO Journal 9(4):1147-1155 (1990).
Huang et al., "Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells." Science 242:1563-1566 (1988).
Huang et al., "A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product." Nature 350:160-162 (1991).
Huang et al., "Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen." The EMBO Journal 9(6):1815-1822 (1990).
Kantoff et al., "Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer." Proc. Natl. Acad. Sci. USA 83:6563-6567 (1986).
Kopelovich and DeLeo, "Elevated Levels of p53 Antigen in Cultured Skin Fibroblasts and Patients with Hereditary Adenocarcinoma of the Colon and Rectum and its Relevance to Oncogenic Mechanisms." JNCI 77(6):1241-1244 (1986).
Kuehn et al., "A potential animal model for Leshc-Nyhan syndrome through introduction of HPRT mutations into mice." Nature 326:295-298 (1987).
Lamb et al., "Characterization of Human p53 Gene." Molecular and Cellular Biol. 6(5):1379-1385 (1986).
Lane et al., "p53: oncogene: or anti-oncogene?" Genes & Development 4:1-8 (1990).
Lavigueur et al., "High Incidence of Lung, Bone, and Lymphoid Tumors in Transgenic Mice Overexpressing Mutant Alleles of the p53 Oncogene." Mol. & Cell. Bio. 9(9):3982-3991 (1989).
Lee et al., "Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers." Science 241:218-221 (1988).
Lee et al., "Molecular cloning of the human esterase D gene, a genetic marker of retinoblastoma." Proc. Natl. Acad. Sci. USA 83:6337-6341 (1986).
Lee et al., "Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79." Proc. Natl. Acad. Sci. USA 85:6017-6021 (1988).
Lee et al., "Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence." Science 235:1394-1399 (1987).
Lee et al., "Purification, biochemical characterization, and biological function of human esterase D." Proc. Natl. Acad. Sci. USA 83:6790-6794 (1986).
Lee et al., "The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity." Nature 329:642-645 (1987).
Lubbert et al., "p53 in chronic myelogenous leukemia." J. Exp. Med. 167:873-886 (1988).
Ludlow et al., "SV40 Large T Antigen Binds Preferentially to an Underphosphorylated Member of the Retinoblastoma Susceptibility Gene Product Family." Cell 56:57-65 (1989).
Mann et al., "Construction of a Retrovirus Packaging Mutant and Its Use to Produce Helper-Free Defective Retrovirus." Cell 33:153-159 (1983).
Matlashewski et al., "Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene." EMBO J. 3(13):3257-3262 (1984).
Mercer et al., "Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells." Proc. Natl. Acad. Sci. USA 79:6309-6312 (1982).
Mercer et al., "Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53." Proc. Natl. Acad. Scie USA 87:6166-6170 (1990).
Miller et al., "Generation of Helper-Free Amphotropic Retroviruses That Transduce a Dominant-Acting, Methotrexate-Resistant Dihydrofolate Reductase Gene." Molecular and Cellular Biol. 5(3):431-437 (1985).
Miller et al., "Transfer of Genes into Human Somatic Cells Using Retrovirus Vectors." Cold Spring Harbor Symposia on Quantitative Biology LI:1013-1019 (1986).
Miller et al., "A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): Gene transfer into cells obtained from humans deficient in HPRT." Proc. Natl. Acad. Sci. USA 80:4709-4713 (1983).
Mowat et al., "Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus." Nature 314:633-636 (1985).
Munroe et al., "Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia." Oncogene 2:621-624 (1988).
Murphree et al., "Retinoblastoma: Clues to Human Oncogenesis." Science 223:1028-1033 (1984).
Nicolau et al., "Liposomes as Carriers for in Vivo Gene Transfer and Expression." Methods in Enzymology 144:157-176.
Nigro, Janice, "Mutations in the p53 gene occur in diverse human tumour types." Nature 342:705-708 (1989).
Parada et al., "Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation." Nature 312:649-651 (1984).
Prokocimer et al., "Expression of p53 in human leukemia and lymphoma." Blood 68(1):113-118 (1986).
Rovinski et al., "Deletion of 5'-coding Sequences of the Cellular p53 Gene in Mouse Erythroleukemia: a Novel Mechanism of Oncogene Regulation." Mol. & Cell. Biol. 7(2):847-853 (1987).
Sager, Ruth, "Tumor Suppress
Chen Phang-Lang
Lee Wen-Hwa
Chambers Jasemine C.
The Regents of the University of California
LandOfFree
Genetic mechanisms of tumor suppression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic mechanisms of tumor suppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic mechanisms of tumor suppression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506436